Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kasofit Q-10
- Development stage
- Phase 1
- Lead developer
- Kaiser Drugs
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Kasofit Q-10 is an oral dietary supplement developed and marketed by Kaiser Drugs Private Limited, an Indian pharmaceutical distributor. The product is a combination of L-carnitine and Coenzyme Q10 (CoQ10), formulated as tablets. Coenzyme Q10 serves as a vital electron carrier in the mitochondrial respiratory chain and acts as a potent lipid-soluble antioxidant, protecting cells from oxidative stress. L-carnitine is an amino acid derivative essential for the transport of long-chain fatty acids into the mitochondrial matrix for energy production via beta-oxidation. Together, these ingredients are intended to provide general nutritional support, enhance mitochondrial health, and provide antioxidant protection.
- Brand names
- Kasofit Q-10
- Other names
- Kasofit Q10
02
Targets
SLC7A1 (Cationic amino acid transporter 1)ETF (Electron transfer flavoprotein)ND1 (Mitochondrial electron transport chain complex I)SDH (Mitochondrial electron transport chain complex II)bc1 complex (Cytochrome bc1 complex (plasmodium))
Beyond the preview
Go deeper on Kasofit Q-10.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kasofit Q-10.